Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 30, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details a specific transaction on November 28, 2006, where Abacus (GSK) Trustees Limited, acting as trustee for the GlaxoSmithKline Employee Trust, transferred 34,200 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. The Company was advised of these transactions on November 29, 2006.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It strictly addresses the disclosure of director and employee trust share interests in accordance with Disclosure Rule 3.1.4R(1)(b).
Key Facts for Investor Verification
- 34,200 Ordinary Shares were transferred from the GSK Trust to employee plan participants on November 28, 2006.
- Directors Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop hold interests in the GSK Trust as potential beneficiaries alongside other employees.
- This filing does not report on the company's operational or financial performance for the period.